Abstract
Along with a well-studied role of polyamines in the regulation of biosynthesis of protein, RNA and DNA, reparative regeneration and oncopathology, the ability of polyamines to act as modulators of neurotransmitter systems in the brain has been shown. There is growing evidence that metabolic abnormalities of polyamines may lead to the development of a number of the central nervous system (CNS) disorders. The study of this problem is important for understanding the molecular basis of pathogenesis and methods of diagnosis of the CNS disorders, as well as for the development of methods for their pharmacological correction on the basis of influence on the polyamine system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
